Literature DB >> 7033856

Retrocorneal pigmentation secondary to iris stromal melanocytic proliferation.

S E Bloomfield, F A Jakobiec, T Iwamoto, W G Harrison.   

Abstract

A 40-year-old black man had two penetrating keratoplasties as a result of complications from alkali burns sustained many years earlier. Two further penetrating keratoplasties were performed for recurrent retrocorneal pigmentation. Both scanning and transmission electron microscopy demonstrated that the retrocorneal pigmented cells were iris melanocytes, based upon their fusiform or dendritic shapes and measurements of their cytoplasmic melanin granules. Repopulation of Descemet's membrane by the melanocytes was produced by a small remnant of atrophic iris. The pigment granules in the iris melanocytes were somewhat larger than those seen in similar cells from Caucasians or Orientals, but had identical measurements to those studied in an iridectomy specimen from another black patient. The retrocorneal iris melanocytes were able to synthesize banded basement membrane material, interrupted laminar basement membrane, and collagen fibrils. The cause of the exfoliation of the iris melanocytes onto the back of the cornea is unknown, but the discovery that iris melanocytes can proliferate in an ongoing fashion and secrete extracellular matrix provides new insight into the physiology of these cells.

Entities:  

Mesh:

Year:  1981        PMID: 7033856     DOI: 10.1016/s0161-6420(81)34878-7

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  2 in total

1.  Recurrent malignant melanoma of the corneal stroma: a case of 'black cornea'.

Authors:  A D Paridaens; C M Kirkness; A Garner; J L Hungerford
Journal:  Br J Ophthalmol       Date:  1992-07       Impact factor: 4.638

2.  Brown cornea.

Authors:  Zita Steiber; Niels Ehlers; Steffen Heegaard; Jesper Hjortdal; Andras Berta; Jan Ulrik Prause
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-01-12       Impact factor: 3.117

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.